Fluorescent nanoparticle probes for imaging of cancer

    Authors

    S. Santra;A. Malhotra

    Comments

    Authors: contact us about adding a copy of your work at STARS@ucf.edu

    Abbreviated Journal Title

    Wiley Interdiscip. Rev.-Nanomed. Nanobiotechnol.

    Keywords

    DOPED SILICA NANOPARTICLES; SEMICONDUCTOR QUANTUM RODS; APTAMER-CONJUGATED NANOPARTICLES; FOLATE-RECEPTOR; IN-VITRO; BIOCONJUGATED NANOPARTICLES; CHITOSAN NANOPARTICLES; NAYF4 NANOCRYSTALS; TARGETED PROBES; DOTS; Nanoscience & Nanotechnology; Medicine, Research & Experimental

    Abstract

    Fluorescent nanoparticles (FNPs) have received immense popularity in cancer imaging in recent years because of their attractive optical properties. In comparison to traditional organic-based fluorescent dyes and fluorescent proteins, FNPs offer much improved sensitivity and photostability. FNPs in certain size range have a strong tendency to enter and retain in solid tumor tissue with abnormal (leaky) vasculature-a phenomenon known as Enhanced Permeation and Retention (EPR) effect, advancing their use for in vivo tumor imaging. Furthermore, large surface area of FNPs and their usual core-shell structure offer a platform for designing and fabricating multimodal/multifunctional nanoparticles (MMNPs). For effective cancer imaging, often the optical imaging modality is integrated with other nonoptical-based imaging modalities such as MRI, X-ray, and PET, thus creating multimodal nanoparticle (NP)-based imaging probes. Such multimodal NP probes can be further integrated with therapeutic drug as well as cancer targeting agent leading to multifunctional NPs. Biocompatibility of FNPs is an important criterion that must be seriously considered during FNP design. NP composition, size, and surface chemistry must be carefully selected to minimize potential toxicological consequences both in vitro and in vivo. In this article, we will mainly focus on three different types of FNPs: dye-loaded NPs, quantum dots (Qdots), and phosphores; briefly highlighting their potential use in translational research. (C) 2011 JohnWiley & Sons, Inc. WIREs Nanomed Nanobiotechnol 2011 3 501-510 DOI: 10.1002/wnan.134

    Journal Title

    Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology

    Volume

    3

    Issue/Number

    5

    Publication Date

    1-1-2011

    Document Type

    Review

    Language

    English

    First Page

    501

    Last Page

    510

    WOS Identifier

    WOS:000298258800006

    ISSN

    1939-5116

    Share

    COinS